SABS logo

SABS

SAB Biotherapeutics, Inc.NASDAQHealthcare
$3.85-0.77%ClosedMarket Cap: $36.8M

As of 2026-04-07

Insider Statistics (Q1 2026)

Purchases

7

Sales

1

Buy/Sell Ratio

7.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed Mar 25Kropotova Alexandraofficer: CHIEF MEDICAL OFFICERSell988$0.0043,296
Thu Feb 05Reich Samuel Jdirector, officer: CEOSell4,800,000$4.454,800,000
Thu Feb 05Bausch Christoph Lawrenceofficer: CHIEF OPERATING OFFICERSell1,800,000$4.451,800,000
Thu Feb 05Kropotova Alexandraofficer: CHIEF MEDICAL OFFICERSell2,400,000$4.452,400,000
Thu Feb 05To Lucyofficer: See RemarksSell2,400,000$4.452,400,000
Thu Feb 05Sullivan Eddie Joedirector, officer: PRESIDENTSell3,000,000$4.453,000,000
Wed Jan 07ZACCARDELLI DAVIDdirectorSell240,000$3.74240,000
Wed Jan 07Jain RitaSell0$0.000
Wed Jan 07ZACCARDELLI DAVIDSell0$0.000
Wed Jan 07Jain RitadirectorSell240,000$3.74240,000
Thu Dec 18SKYLER JAY SdirectorSell150,000$3.99150,000